No abstract

The 15N magnetic shielding anisotropies in nitrous oxide (15N15NO) have been determined using a pulsed FT NMR spectrometer. The shielding anisotropies obtained from the temperature dependence of the nematic phase chemical shifts are 512 ± 10 ppm (central 15N) and 369 ± 15 ppm (end 15N). The values obtained from the nematic-isotropic phase difference method are 505 ± 10 ppm (central 15N) and 366 ± 10 ppm (end 15N). Theoretical estimates of the anisotropies from the so-called atom dipole method are also reported. The indirect scalar coupling constant has been assigned to be negative. The signs of the 15N spin-rotation constants are predicted to be positive.

No abstract

No abstract

Prostate gland is a fibromusculoglandular structure situated at the neck of urinary bladder. So, enlargement or growth of prostate due to nodular hyperplasia (NHP) or prostatic intraepithelial neoplasia (PIN) or adenocarcinoma may give rise to bladder outlet obstruction. Malignant growth i.e., PIN or adenocarcinoma cases are associated with increased blood level of prostate-specific antigen (PSA) and increased expression of different sex-steroid receptors because the growth is dependent on the interactions of androgen, progesterone and estrogen. The aim of our study is to correlate the histopathology, PSA levels and expression of different sex-steroid receptors by immunohistochemistry in different prostatic growth lesions. Among the total 50 cases received, inclusive of transurethral resection of prostate (TURP), transrectal ultrasound-guided biopsy and radical prostatectomy, 34 cases were diagnosed as NHP, 4 cases as PIN and 12 cases as adenocarcinoma histopathologically. Serum PSA values above 10 ng/ml were seen in 2 cases of PIN and 11 cases of adenocarcinoma and none of NHP. Estrogen receptor (ER) () expressions were negative in all cases. Progesterone receptor (PR) expressions were strongly positive in 35% cases of both NHP and adenocarcinoma, whereas androgen receptor (AR) expressions were strong among all cases of adenocarcinoma and only in four cases of NHP. By observing these findings it can be suggested that antiandrogen and antiprogesterone therapy simultaneously will do better than antiandrogen alone in treating prostatic growth lesions.